Breakthrough in ophthalmology: Crosslinking treatment shows expanded indications beyond keratoconus, offering renewed hope for patients with various corneal disorders. Recent studies highlight its effectiveness in treating conditions like corneal ectasia and pellucid marginal degeneration, revolutionizing treatment options for those previously deemed ineligible. With promising outcomes, this advancement signals a new era in eye care, potentially transforming the lives of countless individuals worldwide.
Studies: Crosslinking with expanded indications
